ReviewJournal of ultrasonography2026
Microvascular flow imaging in musculoskeletal ultrasound: from technical innovation to clinical integration.
Review in Journal of ultrasonography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in Doppler ultrasound have led to the development of microvascular flow imaging, a technique designed to overcome the limitations of color and Power Doppler in detecting slow, small-vessel flow. This narrative review summarizes the technical foundations, clinical applications, and emerging perspectives of microvascular technologies in musculoskeletal ultrasound, emphasizing their role as a bridge between morphological and functional imaging. Microvascular flow imaging employs spatiotemporal clutter-suppression algorithms and high-frame-rate acquisition to visualize low-velocity blood flow within capillaries smaller than 100 µm, without the need for contrast agents. The method enhances detection of microvascularity in tendons, synovium, and peripheral nerves, providing early indicators of inflammatory or degenerative activity. Proprietary vendor implementations share the same physical principles but differ in algorithmic filtering and signal rendering. Clinically, microvascular flow imaging has demonstrated superior sensitivity compared with Power Doppler for detecting subclinical synovitis, assessing tendinopathies, and evaluating entrapment neuropathies, offering both quantitative and prognostic insights. Although microvascular flow imaging improves diagnostic sensitivity and supports dynamic, contrast-free assessment of tissue perfusion, its routine implementation remains limited by the absence of standardized acquisition protocols, validated quantitative metrics, and inter-vendor harmonization. Ongoing research into AI-based vascular quantification and portable point-of-care systems may enhance reproducibility, accessibility, and integration into everyday musculoskeletal imaging. Overall, microvascular flow imaging represents a pivotal step toward functional musculoskeletal ultrasound, with expanding diagnostic, prognostic, and theranostic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.